Question

a discussion of the company Amgen growth and future prospects

Answer 1

Amgen Inc. is one of the world's largest biotechnological and biopharmaceutical company. It is an American multinational company situated in Thousand oaks , California. It is established in 1980 and having a current stock value of $223.48 . At the Morgan Stanley 17 th Annual Global Healthcare Conference, CEO Bob Bradway and CFO David Meline have pointed out to the future plans and prospects of Amgen Inc. The Company is facing higher competitions from the other competitors and planning to overcome the hazards by implementing some new policies.

Main future prospects of Amgen Inc as CEO and CFO stated are as follows.

Changes to drug pricing

Drug pricing is a main huddle to the investor's of pharmaceutical company. Pricing of drugs are always a challenging process. Drugs are looting the money of patients who are suffering. So at the conference Amgen Inc. has put forward some interesting suggestions to the drug pricing.

More acquisition

As stated by their CEO and CFO, Amgen is in deal to buy the psoriasis drug otezla from celgene. This will make a great impact in the company and its market value.

Big opportunities in Oncology

Company has recently announced data from a phase 1 study of the drug that found out that a 950 mg dose of a drug kept non small cell lung cancer from progressing in 100% of patients , with tumors shrinking more than half of the patients

More buybacks and higher dividend

The Amgen inc. is planning to more buybacks of stocks and distribution of higher dividend. Milene said that Company is not going to sit with the excess cash and they are planning to treat their investors more happy.

Adding otzela and some other drugs will make their product mix more attractive and they think that will help their growth .